Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC)

被引：2
|
作者：
Bauman, J. [1 ]
Ferris, R. L. [2 ]
Clump, D. A. [1 ]
Ohr, J. [1 ]
Gooding, W. [1 ]
Kim, S. [2 ]
Karlovits, B. [2 ]
Duvvuri, U. [2 ]
Johnson, J. T. [2 ]
Petro, D. [1 ]
Heron, D. [1 ]
机构：
[1] UPMC, Hillman Canc Ctr, UPCI, Pittsburgh, PA USA
[2] Univ Pittsburgh, Inst Eye & Ear, Dept Otolaryngol, Div Head & Neck Surg, Pittsburgh, PA 15213 USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw435.31
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA36
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma
    Francesca De Felice
    Luigia Vetrone
    Nadia Bulzonetti
    Rossella Caiazzo
    Francesco Marampon
    Daniela Musio
    Vincenzo Tombolini
    Medical Oncology, 2019, 36
  • [32] Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma
    De Felice, Francesca
    Vetrone, Luigia
    Bulzonetti, Nadia
    Caiazzo, Rossella
    Marampon, Francesco
    Musio, Daniela
    Tombolini, Vincenzo
    MEDICAL ONCOLOGY, 2019, 36 (08)
  • [33] Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial
    Elbers, Joris B. W.
    Al-Mamgani, Abrahim
    Tesseslaar, Margot E. T.
    van den Brekel, Michiel W. M.
    Lange, Charlotte A. H.
    van der Wal, Jacqueline E.
    Verheij, Marcel
    Zuur, Charlotte L.
    de Boer, Jan Paul
    RADIOTHERAPY AND ONCOLOGY, 2020, 142 : 79 - 84
  • [34] A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma
    Steinberg, L
    Hassan, M
    Olmsted, L
    Sharan, V
    Stepnick, D
    Hoppel, C
    Mugharbil, A
    Subramanyan, S
    McGloin, B
    Mackay, W
    Strauss, M
    SEMINARS IN ONCOLOGY, 1997, 24 (06) : S51 - S56
  • [35] Mono centric experience of concurrent Radiotherapy and Cetuximab in the treatment of locally advanced squamous cell carcinoma of the head and neck
    Roman, J.
    Miglierini, P.
    Le Fur, E.
    Miranda, O.
    Pradier, O.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 100 - 100
  • [36] A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma
    Tao, Yungan
    Rezai, Keyvan
    Brain, Etienne
    Etessami, Atoussa
    Lusinchi, Antoine
    Temam, Stephane
    Urien, Sail
    Van, Marie-Louise Vo
    Vauzelle-Kervroedan, Francoise
    Lokiec, Francois
    Daly-Schveitzer, Nicolas
    Bourhis, Jean
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 (01) : 42 - 47
  • [37] A Phase I Study of the CDK4/6 Inhibitor Palbociclib in Combination with Cetuximab and Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
    Ngamphaiboon, Nuttapong
    Pattaranutaporn, Poompis
    Lukerak, Somthawin
    Siripoon, Teerada
    Jinawath, Artit
    Arsa, Lalida
    Shantavasinkul, Prapimporn Ch.
    Taonam, Naphat
    Trachu, Narumol
    Jinawath, Natini
    Kositwattanarerk, Arpakorn
    Sananmuang, Thiparom
    Jiarpinitnun, Chuleeporn
    CLINICAL CANCER RESEARCH, 2024, 30 (02) : 294 - 303
  • [38] Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial
    Kies, Merrill S.
    Holsinger, Floyd Christopher
    Lee, J. Jack
    William, William N., Jr.
    Glisson, Bonnie S.
    Lin, Heather Y.
    Lewin, Jan S.
    Ginsberg, Lawrence E.
    Gillaspy, Katharine A.
    Massarelli, Erminia
    Byers, Lauren
    Lippman, Scott M.
    Hong, Waun K.
    El-Naggar, Adel K.
    Garden, Adam S.
    Papadimitrakopoulou, Vassiliki
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 8 - 14
  • [39] Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional chemo-radiotherapy for locally advanced (LA) head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial
    Tao, Y.
    Auperin, A.
    Blanchard, P.
    Alfonsi, M.
    Sun, X-S.
    Rives, M.
    Pointreau, Y.
    Castelli, J.
    Graff, P.
    Kam, S. Wong Hee
    Thariat, J.
    Veresezan, O.
    Cornely, A.
    Casiraghi, O.
    Lapeyre, M.
    Bourhis, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [40] Nimotuzumab in combination with intensity modulated radiotherapy improve survival in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A multicenterbased real-world study
    Yi, Junlin
    Lang, Jin Yi
    Zhang, Chenping
    Zhang, Xin-Xin
    Wu, Shao-xiong
    Sun, Yan
    Wang, Peiguo
    Qiu, Sufang
    Huang, Xiaodong
    Zhang, Peng
    Ren, Guoxin
    Liu, Kun
    Du, Xiao-Jing
    Xiao, Shaowen
    Wang, Zhong Qiu
    Weng, Youliang
    Zhang, Ye
    Zhou, Hang
    Tu, Wenyong
    Bai, Xianhong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345